Deadline: 29 Oct 2032
United Kingdom
Ref. No.: 20501670
EMD:Ref Document
Bid Value: Ref Document
2507 Days Left
Deadline: 31 Jul 2028
United Kingdom
Ref. No.: 20501654
EMD:Ref Document
Bid Value: Ref Document
956 Days Left
Deadline: 16 Oct 2030
United Kingdom
Ref. No.: 20501640
EMD:Ref Document
Bid Value: Ref Document
1763 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501627
EMD:Ref Document
Bid Value: Ref Document
1163 Days Left
Deadline: 16 May 2026
United Kingdom
Ref. No.: 20501620
EMD:Ref Document
Bid Value: Ref Document
149 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501603
EMD:Ref Document
Bid Value: Ref Document
1163 Days Left
Deadline: 16 May 2026
United Kingdom
Ref. No.: 20501571
EMD:Ref Document
Bid Value: Ref Document
149 Days Left
Deadline: 01 Oct 2032
United Kingdom
Ref. No.: 20501566
EMD:Ref Document
Bid Value: Ref Document
2479 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501563
EMD:Ref Document
Bid Value: Ref Document
1163 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20500236
EMD:Ref Document
Bid Value: Ref Document
621 Days Left
Deadline: 31 Dec 2031
Finland
Ref. No.: 20498561
EMD:Ref Document
Bid Value: Ref Document
2204 Days Left
Open House Pharmaceutical Discounts On The Active Ingredient Natalizumab S C Daring Form Atc L04Ag03
Deadline: 31 Aug 2027
Germany
Ref. No.: 20494511
EMD:Ref Document
Bid Value: Ref Document
621 Days Left
Deadline: 30 Sep 2026
United States
Ref. No.: 20486063
EMD:Ref Document
Bid Value: Ref Document
286 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20485097
EMD:Ref Document
Bid Value: Ref Document
621 Days Left
Spain
Ref. No.: 20484973
EMD:Ref Document
Bid Value: Ref Document
1003 Days Left